---
title: "000590.SZ (000590.SZ) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/000590.SZ/news.md"
symbol: "000590.SZ"
name: "000590.SZ"
parent: "https://longbridge.com/zh-CN/quote/000590.SZ.md"
datetime: "2026-03-17T07:33:12.027Z"
locales:
  - [en](https://longbridge.com/en/quote/000590.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000590.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000590.SZ/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/000590.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/000590.SZ/news.md)


# 000590.SZ (000590.SZ) — 相关新闻

### [Two Sessions | National People's Congress representative and Chief Consultant of GUHAN-PHARMA, Jiao Qisen: Promote the transformation of in-hospital traditional Chinese medicine preparations into new drugs](https://longbridge.com/zh-CN/news/278484111.md)
*2026-03-10T03:16:13.000Z*
> Jiao Qisen, a representative of the National People's Congress and the chief consultant of GUHAN-PHARMA, proposed multip

### [GUHAN-PHARMA shareholder Shanghai Sailoxian plans to invest no less than 20 million yuan to implement a buyback](https://longbridge.com/zh-CN/news/278372244.md)
*2026-03-09T10:25:02.000Z*
> One of the controlling shareholders of GUHAN-PHARMA, Shanghai Sailoxian Enterprise Management Consulting Co., Ltd., plan

### [Four companies collectively accepted hearings, and the regulation of the entire chain in the pharmaceutical field is gaining momentum again](https://longbridge.com/zh-CN/news/277021631.md)
*2026-02-26T10:09:12.000Z*
> The State Administration for Market Regulation will hold hearings on February 28 for four pharmaceutical companies, incl

### [GUHAN-PHARMA: Expected net loss of RMB 45 million to RMB 55 million in 2025](https://longbridge.com/zh-CN/news/274137025.md)
*2026-01-29T11:00:45.000Z*
> GUHAN-PHARMA announced that it expects a net profit loss of 45 million to 55 million yuan for the fiscal year 2025. Affe

### [GUHAN-PHARMA Jiang Lin: The goal for 2026 is to restore production of over 30 varieties and lay a solid foundation for development](https://longbridge.com/zh-CN/news/273022338.md)
*2026-01-20T02:52:09.000Z*
> On January 19th, GUHAN-PHARMA (000590) held its 30th anniversary celebration of its main board listing in Changsha, Huna

### [TUS-PHARMA: Plans to change its stock abbreviation to "GuHan Pharmaceutical"](https://longbridge.com/zh-CN/news/270478341.md)
*2025-12-22T10:37:06.000Z*
> TUS-PHARMA announced that the company's tenth board of directors held a temporary meeting via communication voting, agre

### [TUS-PHARMA plans to change its name to "GuHan Pharmaceutical Group Co., Ltd."](https://longbridge.com/zh-CN/news/267494695.md)
*2025-11-26T09:52:09.000Z*
> TUS-PHARMA announced that the company's board of directors has approved the proposal to change its name to "GuHan Pharma

### [TUS-PHARMA: The net profit for the third quarter was 2.3495 million yuan, a year-on-year increase of 146.43%](https://longbridge.com/zh-CN/news/263277182.md)
*2025-10-29T11:34:32.000Z*
> TUS-PHARMA announced that its revenue for the third quarter was 82.3783 million yuan, a year-on-year increase of 18.40%;

### [TUS-PHARMA and MicuRx change ownership, accelerating the reshuffling of the pharmaceutical industry](https://longbridge.com/zh-CN/news/258801936.md)
*2025-09-25T00:54:11.000Z*
> TUS-PHARMA and MicuRx's recent changes in control have attracted market attention. TUS-PHARMA announced that its control

### [The TUS-PHARMA system exits, 80s-born Jiang Lin fully takes over TUS-PHARMA: Management has completed a blood transfusion, integration may face challenges](https://longbridge.com/zh-CN/news/258771760.md)
*2025-09-24T23:36:28.000Z*
> On September 24th, TUS-PHARMA announced a change in control, with the TUS system officially exiting. Post-80s entreprene